Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
130.90    -0.70 (-0.53%)
Bid:
131.30
Ask:
131.60
Spread: 0.30 (0.228%)
Market Cap: £331.03m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Director/PDMR Shareholding

17 Nov 2008 13:59

RNS Number : 2999I
Marshalls PLC
17 November 2008
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

1.Β Name of theΒ issuer

Marshalls plc

-----------------------------------------

2.Β State whether the notification relates to (i) a transaction notified in accordance withΒ DRΒ 3.1.4R(1)(a); or

(ii)Β DRΒ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; orΒ 

(iii) both (i) and (ii)

(i)

----------------------------------------

3.Β Name ofΒ person discharging managerial responsibilities/director

Michael Davies

Chris Harrop

-----------------------------------------

4.Β State whether notification relates to aΒ personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person

N/A

----------------------------------------

5.Β Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest

Michael Davies

Chris Harrop

----------------------------------------

6.Β Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares

Ordinary Shares of 25 pence each

----------------------------------------

7.Β Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them

Michael Davies :Β 35,000 shares

Chris Harrop : 4,940 shares

----------------------------------------

8.Β State the nature of the transaction

Acquisition of shares

----------------------------------------

9.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired

Michael Davies :Β 10,000 shares

Chris Harrop : 2,000 shares

-----------------------------------------

10.Β Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)

Michael Davies : 0.007%

Chris Harrop : 0.0014%

----------------------------------

11.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed

N/A

12.Β Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)Β 

N/A

13.Β Price perΒ shareΒ or value of transaction

Michael Davies :Β 85Β pence per share

Chris Harrop : 85.5 pence per share

---------------------------------------------

14.Β Date and place of transaction

Michael Davies : 17 November 2008

Chris Harrop : 14 November 2008

--------------------------------------------

15.Β Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage)

Michael Davies :Β 45,000 shares : 0.032%

Chris Harrop : 6,940 shares : 0.0049%

-------------------------------------

16.Β Date issuer informed of transaction

Michael Davies : 17 November 2008

Chris Harrop : 14 November 2008

------------------------------------

If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes

17.Β Date of grant

N/A

………………………………

18.Β Period during which or date on which it can be exercised

N/A

………………………………

19.Β Total amount paid (if any) for grant of the option

N/A

………………………………

20.Β Description ofΒ sharesΒ or debentures involved (classΒ and number)

N/A

………………………………

………………………………

21.Β Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

N/A

………………………………

22.Β Total number ofΒ sharesΒ or debentures over which options held following notification

N/A

………………………………

23.Β Any additional information

………………………………

24.Β Name of contact and telephone number for queries

C E Baxandall, 01484 438900

………………………………

Name and signature of duly authorised officer ofΒ issuerΒ responsible for making notification

C E Baxandall

………………………………

Date of notification

17 November 2008

………………………………

ENDΒ 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSEADFXFSSPFFE
Date   Source Headline
12th Nov 202412:02 pmRNSDirector/PDMR Shareholding
12th Nov 202411:47 amRNSDirector/PDMR Shareholding
12th Nov 202411:44 amRNSDirector/PDMR Shareholding
31st Oct 202411:18 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSQ3 Trading Update
15th Oct 20249:45 amRNSDirector/PDMR Shareholding
15th Oct 20249:43 amRNSDirector/PDMR Shareholding
15th Oct 20249:42 amRNSDirector/PDMR Shareholding
10th Sep 20244:59 pmRNSDirector/PDMR Shareholding
23rd Aug 20242:57 pmRNSDirector/PDMR Shareholding
16th Aug 202411:21 amRNSHolding(s) in Company
12th Aug 20247:00 amRNSHalf-year Report
25th Jul 20247:00 amRNSNotice of Interim Results
3rd Jun 20243:17 pmRNSDirector/PDMR Shareholding
15th May 20241:01 pmRNSResult of AGM
15th May 20247:00 amRNSTrading Statement
29th Apr 20243:25 pmRNSDirector/PDMR Shareholding - Correction
29th Apr 202411:45 amRNSDirector/PDMR Shareholding
19th Apr 20248:51 amRNSHolding(s) in Company
10th Apr 20242:03 pmRNSAnnual Financial Report
22nd Mar 202412:40 pmRNSDirector/PDMR Shareholding
19th Mar 20242:00 pmRNSDirector/PDMR Shareholding
19th Mar 20241:59 pmRNSDirector/PDMR Shareholding
19th Mar 20241:57 pmRNSDirector/PDMR Shareholding
19th Mar 20241:56 pmRNSDirector/PDMR Shareholding
18th Mar 202412:07 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSFinal Results
26th Feb 202410:36 amRNSDirector/PDMR Shareholding
15th Feb 20249:49 amRNSHolding(s) in Company
1st Feb 202411:59 amRNSHolding(s) in Company
31st Jan 20241:17 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:36 amRNSHolding(s) in Company
6th Dec 20237:00 amRNSCEO Succession
1st Dec 20233:08 pmRNSHolding(s) in Company
28th Nov 20233:17 pmRNSHolding(s) in Company
7th Nov 20231:47 pmRNSStatement re 2023 AGM Remuneration Report Vote
3rd Nov 202310:38 amRNSDirector Declaration
27th Oct 20239:56 amRNSHolding(s) in Company
23rd Oct 20234:14 pmRNSHolding(s) in Company
20th Oct 202310:36 amRNSHolding(s) in Company
18th Oct 20234:04 pmRNSHolding(s) in Company
18th Oct 20234:02 pmRNSHolding(s) in Company
18th Oct 202312:38 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSTrading Statement
17th Oct 202311:52 amRNSHolding(s) in Company
6th Oct 20233:39 pmRNSHolding(s) in Company
4th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:08 pmRNSHolding(s) in Company
17th Aug 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.